Aagya Biotech is a pharmaceutical company located in Roorkee, Haridwar, Uttarakhand, India, specializing in the manufacturing and exporting of WHO-GMP and ISO 9001:2015 certified pharmaceutical finished dosage formulations. Established in 2017, it is a part of the GS Pharmaceuticals group founded in 1979. The company operates state-of-the-art manufacturing facilities including Unit-I for general formulations, Unit-II for beta-lactam formulations, and Unit-III for cephalosporins formulations, all of which are WHO-GMP and ISO 9001:2015 certified. Moreover, Aagya Biotech is a trusted supplier and trader of high-quality APIs, making it a preferred partner for pharmaceutical companies. With a focus on manufacturing and the pharmaceutical industry, Aagya Biotech presents an opportunity for potential investors to tap into a company with a solid reputation for quality and compliance.
There is no investment information
No recent news or press coverage available for Aagya Biotech.